More than 80% of the victims who took Kobayashi pharmaceutical monaskoji health products did not improve their kidney function
More than 80% of the 206 patients with kidney dysfunction who took Kobayashi Pharmaceutical's health care products containing monaskoji did not improve their kidney function after treatment, and some patients suffered systemic failure after hospitalization, according to a survey released by the Japanese Society of Nephrology on Sunday (June 30).
more